Using natural killer cell‐derived exosomes as a cell‐free therapy for leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Using natural killer cell‐derived exosomes as a cell‐free therapy for leukemia

Published:2022-12-08 Issue: Volume: Page:
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Samara Aladin¹,Anbar Michael¹,Shapira Saar¹,Zemlyansky Anna²,Zozovsky Alla²,Raanani Pia³⁴,Granot Galit¹^ORCID,Rozovski Uri³⁴

Affiliation:

1. Felsenstein Medical Research Center Rabin Medical Center Petah Tikva Israel

2. The Rina Zaizov Pediatric Hematology and Oncology Division Schneider Children's Medical Center Rabin Medical Center Petah Tikva Israel

3. Hematology Division Davidoff Cancer Center Rabin Medical Center Petah Tikva Israel

4. Sackler School of Medicine Tel Aviv University Tel Aviv Israel

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3111

Reference48 articles.

1. The Principles of Engineering Immune Cells to Treat Cancer

2. CAR T cell immunotherapy for human cancer

3. Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'

4. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells

5. CAR T-Cell Associated Neurotoxicity: Mechanisms, Clinicopathologic Correlates, and Future Directions

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes of immune cell origin and their therapeutic potential for tumors;VIEW;2024-09-02

2. Different origin-derived exosomes and their clinical advantages in cancer therapy;Frontiers in Immunology;2024-06-27

3. Leukemogenesis occurs in a microenvironment enriched by extracellular microvesicles/exosomes: recent discoveries and questions to be answered;Leukemia;2024-02-22

4. Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules;Frontiers in Oncology;2024-01-08

5. NK3.3-Derived Extracellular Vesicles Penetrate and Selectively Kill Treatment-Resistant Tumor Cells;Cancers;2023-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3